Letters by company
Barclays PLC
3 letters discussing BCS. Everything written about it on this site is on its ticker page.
- Smead Capital Management 1Q26 International Value Strategy Newsletter: Succeeding Unconventionally Smead International Value Strategy concentrates in oil equities after the prior energy capital-spending boom left supply constrained and producers reluctant to expand. It argues that European banks’ cost discipline, buybacks and potential consolidation can sustain returns on capital, while reviewing recoveries in Burberry, Glencore, Frontline and Next. 1Q26 BAWAY $15BBBRYF $5.1BBCS $77B
- Pittenger & Anderson 2026 – 3rd Quarter Letter – Wall of Worry Revisited Pittenger & Anderson uses the post-9/11 recovery to argue that remaining invested is necessary to participate in innovation despite fear and volatility. It frames AI spending, power demand, regulation and financing as the market’s current wall of worry, while directing clients to service advisers for account transfers, IRA distributions and charitable gifts. Q3 2026 AAPL $5.2TAMZN $2.9TGOOGL $3.6T
- Cambiar Investors Cambiar International Equity Fund Commentary Cambiar International Equity Fund lagged its benchmark as an underweight technology allocation missed an AI-driven semiconductor rally, while patient holdings in Nintendo, Coloplast and MonotaRo hurt shorter-term results. The team added Canadian National Railway and MTU Aero Engines, sold Barry Callebaut, Icon and UCB, and maintained a diversified, valuation-conscious approach with greater Industrials exposure. 2Q 2026 CNI $76BICLR $15BLDNXF $62B
